Impacts of Thyroid Eye Disease (TED), Beyond the Signs and Symptoms: Results from the ElevaTED Patient Survey [0.03%]
甲状腺眼病（TED）的影响超出了体征和症状：ElevaTED患者调查的结果
Jody G Abrams,Christine Gustafson,Sherry R Danese et al.
Jody G Abrams et al.
Introduction: Thyroid eye disease (TED) can be visually debilitating and cosmetically disfiguring. Symptoms vary in severity and can lead to drastically impaired quality of life (QoL), ability to work, and mental health. ...
Understanding Patient Preferences and Their Impact on Adherence to Glaucoma Therapy: A Multicenter Cross-Sectional Study [0.03%]
理解患者偏好及其对青光眼治疗依从性的影响：一项多中心横断面研究
Tomás Hernández,Sara Labay,Susana Duch et al.
Tomás Hernández et al.
Introduction: Glaucoma is a progressive, irreversible optic neuropathy that leads to the loss of retinal ganglion cells, vision loss, and blindness. Elevated intraocular pressure (IOP) is the only modifiable risk factor, ...
Deepika C Parameswarappa,Dhanashree Ratra,Goura Chattannavar et al.
Deepika C Parameswarappa et al.
ABCA4-associated retinopathies (Stargardt disease) are the most common inherited macular dystrophy and a leading cause of early onset central vision loss. Biallelic pathogenic variants in the ABCA4 gene cause impaired clearance of retinoid ...
Spectrally Resolved (Colour-Coded) Fundus Autofluorescence Using the EIDON System in Vitreoretinal Lymphoma [0.03%]
采用EIDON系统进行光谱解析型（用颜色编码）的视网膜自发荧光在玻璃体视网膜淋巴瘤中的应用研究
Alessandro Marchese,Riccardo Sacconi,Matteo Menean et al.
Alessandro Marchese et al.
Introduction: This study evaluates colour-coded fundus autofluorescence (FAF) in vitreoretinal lymphoma (VRL), which still represents a diagnostic challenge because of the variety of ocular manifestations and difficulties...
Safety of GBL1204-An Ophthalmic Bevacizumab in Prefilled Syringe for Neovascular Age-Related Macular Degeneration: A Phase I Study [0.03%]
GBL1204玻璃体内注射治疗湿性年龄相关性黄斑变性的I期临床试验：预装式贝伐单抗注射液的安全性研究
Amit Saraf,Kushal Garima,Sandhya Dharwadkar et al.
Amit Saraf et al.
Introduction: GBL1204 1.25 mg is an ophthalmic-grade bevacizumab formulation, manufactured in accordance with the stringent ophthalmic quality standards, and supplied in a single-use prefilled syringe (PFS). This clinical...
A Multimodal Approach to Open-Angle Glaucoma with Travoprost Intracameral Implant and Minimally Invasive Glaucoma Surgery with or Without Concurrent Cataract Surgery [0.03%]
travoprost玻璃体内植入物联合微创青光眼手术治疗开角型青光眼科题：伴或不伴有同时进行的白内障手术
Christine Funke,Chloe CoHan
Christine Funke
Introduction: This study aimed to characterize reductions in intraocular pressure (IOP) and the need for topical IOP-lowering medications in eyes undergoing implantation of a travoprost implant (iDose TR®; Glaukos) and e...
Efficacy and Safety Outcomes of Fluocinolone Acetonide Intravitreal Implant in Refractory Diabetic Macular Edema: A Real-World Study [0.03%]
氟氯喹醇 acetone植入治疗难治性糖尿病黄斑水肿的真实世界疗效及安全性研究
João Castro Cabanas,Daniel Ferreira Cardoso,Catarina Cunha Ferreira et al.
João Castro Cabanas et al.
Introduction: This study aimed to evaluate the long-term efficacy and safety of the 0.19 mg fluocinolone acetonide (FAc) intravitreal implant in patients with refractory diabetic macular edema (DME). ...
Real-World Utilization and Initial Experience with Aflibercept-ayyh (PAVBLU®) for Retinal Disorders in United States Retina Practices: A Descriptive Retrospective Analysis [0.03%]
描述性回顾分析：美国视网膜疾病临床实践中Aflibercept-ayyh(PAVBLU®)的使用和初步经验
Argentina E Servin,Ian McFadden,Houri Esmaeilkhanian et al.
Argentina E Servin et al.
Introduction: Anti-vascular endothelial growth factor (anti-VEGF) therapies are standards of care for vision-threatening retinal diseases. This retrospective observational study describes demographics, utilization, best r...
Real-World Outcomes After Switching to Faricimab in Patients with Chronic Diabetic Macular Edema at a Tertiary Eye Center in Singapore [0.03%]
新加坡三级眼科中心糖尿病黄斑水肿患者 switched to Faricimab后的实际疗效
Kanae Fukutsu,Rose Ann Goh,Fang Zheng et al.
Kanae Fukutsu et al.
Introduction: To evaluate visual and anatomical outcomes after switching to faricimab in Singaporean patients with diabetic macular edema (DME) previously treated with other anti‑vascular endothelial growth factor (VEGF)...
Carla Lanca,Ian Morgan,Andrzej Grzybowski
Carla Lanca
Our commentary critically examines whether the widely accepted projection of a global myopia epidemic, most prominently proposed by Holden et al. (2016), adequately reflects the European context. These projections assume that most regions o...